Navigating Challenges in Biotech and Gene Therapy

This chapter examines the shifting dynamics in the biotech industry, emphasizing the rise of smaller companies and the impact of financial changes. It particularly highlights the challenges faced by the gene therapy market, including the underperformance of treatments and the looming uncertainty surrounding 2025. The discussion also touches on the competitive landscape and key upcoming drug launches that could alter the course of the industry.